Symtuza Regular Drug Use-Results Survey

Not Applicable

Recruiting

• Conditions: HIV/AIDS

• Registration Number: JPRN-UMIN000037485
• Lead Sponsor: Janssen Pharmaceutical K.K.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-26
• Last Update Posted: 17 October 2023
• Study Completion: 2025-03-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

Not provided

Exclusion Criteria

NA

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Safety (ADR) Effectiveness( Changes in HIV-RNA level, Changes in CD4 lymphocyte count)